Catenion -- Management Consultants
About -- Catenion Catenion's Services Catenion's Clients Catenion's Insights Careers at Catenion Contact Catenion
Catenion

Spotlight

Executive Briefing on Post Merger Integration — Capturing Deal Value through Strategic Vision and Rigorous Process

There are many valid reasons why companies pursue mergers & acquisitions (M&A) as part of their strategic growth plans. These include portfolio diversification, addition of top–line growth, acquisition of key technology, geographical expansion, or some combination of the above. However, the acquiring company is typically required to pay a premium of up to 30% in order to win the deal competition, and to satisfy shareholders of the target company.
Download this executive briefing…


Revitalizing portfolio decision-making at Merck Serono SA–Geneva

In this new article we discuss a short history of portfolio management, identify eight possible limiting factors, and a step–wise process to overcome these situations all in the context of post–merger Merck Serono.
Download this article…


Catenion is a management consulting firm devoted to helping pharmaceutical and medical products companies significantly increase the returns on their R&D and marketing investments by creating more innovative and effective strategies and organisations. Read more...



"I tremendously enjoyed working with Catenion. They are fully at home in pharmaceutical Discovery and bring a highly unusual combination of a rigorous analytical mind–set with a pragmatic understanding of R&D strategy and organisational mechanics."


Dr. Gianni Gromo
Global Head Metabolic &
Vascular Disease Area
F. Hoffmann–La Roche AG


Read more client testimonials...